Czechia, Dec. 1 -- Czechia based Fresenius Kabi s.r.o. has secured contract from Fakultni nemocnice Olomouc for Antineoplastic and immunomodulating agents - LP s obsahem bendamustinu 2025. The value of the contract is worth 308464623 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....